Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lung.
about
Phase II cancer prevention clinical trialsLung cancer chemoprevention with celecoxib in former smokers.Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers.Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
P2860
Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lung.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@ast
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@en
type
label
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@ast
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@en
prefLabel
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@ast
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@en
P2860
P1476
Assessing efficacy in early-ph ...... the case of ki-67 in the lung.
@en
P2093
P2860
P304
P356
10.1158/1940-6207.CAPR-09-0268
P577
2010-01-26T00:00:00Z